Matinas BioPharma Holdings (MTNB) Net Margin (2015 - 2023)
Matinas BioPharma Holdings' Net Margin came in at -2093.25% for FY2023, down 1434.62 percentage points from -658.63% in FY2022.
Analysis
Matinas BioPharma Holdings (MTNB) Net Margin (2015 - 2023) Analysis & Trends
Going back to FY2015, Matinas BioPharma Holdings' Net Margin data covers 8 years.
- Net Margin carries a five-year change of +10422.92 percentage points (FY2018 to FY2023).
- The five-year range for annual Net Margin is -71754.55% (FY2021) to -658.63% (FY2022).
- Per Business Quant, earlier years put Net Margin at -658.63% in FY2022 (+71095.92 pp), -71754.55% in FY2021 (-57076.44 pp), -14678.10% in FY2020 (+5694.24 pp) and -20372.35% in FY2019 (-7856.17 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Matinas BioPharma Holdings | 16.27 Mn | 3.68 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -503.01% |
| Dec 31, 2022 | -341.91% |
| Sep 30, 2022 | -513.79% |
| Jun 30, 2022 | -557.16% |
| Mar 31, 2021 | -15,501.82% |
| Dec 31, 2020 | -10,494.29% |
| Sep 30, 2020 | -5,923.96% |
| Jun 30, 2019 | -4,016.46% |
| Jun 30, 2018 | -3,985.69% |
| Mar 31, 2018 | -14,220.83% |
| Dec 31, 2017 | -8,404.61% |
| Sep 30, 2017 | -7,895.38% |
| Jun 30, 2017 | -9,174.81% |
| Mar 31, 2017 | -142,938.56% |
| Sep 30, 2015 | -3,599.56% |
| Jun 30, 2015 | -3,122.77% |
| Mar 31, 2015 | -4,459.21% |
API Access
Matinas BioPharma Holdings Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=MTNB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();